153 related articles for article (PubMed ID: 38593778)
1. Targeting APOBECs in cancer: It's about timing.
Hata AN; Larijani M
Cancer Cell; 2024 Apr; 42(4):497-501. PubMed ID: 38593778
[TBL] [Abstract][Full Text] [Related]
2. Addressing the benefits of inhibiting APOBEC3-dependent mutagenesis in cancer.
Petljak M; Green AM; Maciejowski J; Weitzman MD
Nat Genet; 2022 Nov; 54(11):1599-1608. PubMed ID: 36280735
[TBL] [Abstract][Full Text] [Related]
3. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential.
Butler K; Banday AR
J Hematol Oncol; 2023 Mar; 16(1):31. PubMed ID: 36978147
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.
Roelofs PA; Martens JWM; Harris RS; Span PN
Clin Cancer Res; 2023 May; 29(9):1658-1669. PubMed ID: 36478188
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs regulate APOBEC gene expression.
Cao W; Wu W
Histol Histopathol; 2018 Feb; 33(2):117-120. PubMed ID: 28604942
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like family genes activation and regulation during tumorigenesis.
Gao J; Choudhry H; Cao W
Cancer Sci; 2018 Aug; 109(8):2375-2382. PubMed ID: 29856501
[TBL] [Abstract][Full Text] [Related]
7. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
Swanton C; McGranahan N; Starrett GJ; Harris RS
Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
[TBL] [Abstract][Full Text] [Related]
8. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
[TBL] [Abstract][Full Text] [Related]
9. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.
Roberts SA; Lawrence MS; Klimczak LJ; Grimm SA; Fargo D; Stojanov P; Kiezun A; Kryukov GV; Carter SL; Saksena G; Harris S; Shah RR; Resnick MA; Getz G; Gordenin DA
Nat Genet; 2013 Sep; 45(9):970-6. PubMed ID: 23852170
[TBL] [Abstract][Full Text] [Related]
10. The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer.
Liu W; Newhall KP; Khani F; Barlow L; Nguyen D; Gu L; Eng K; Bhinder B; Uppal M; Récapet C; Sboner A; Ross SR; Elemento O; Chelico L; Faltas BM
Cancer Res; 2023 Feb; 83(4):506-520. PubMed ID: 36480186
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma.
Soikkeli AI; Kyläniemi MK; Sihto H; Alinikula J
Cancer Res Commun; 2022 Nov; 2(11):1344-1354. PubMed ID: 36970060
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like Gene Expression, RNA Editing, and MicroRNAs Regulation.
Cao W; Wu W
Methods Mol Biol; 2018; 1699():75-81. PubMed ID: 29086369
[TBL] [Abstract][Full Text] [Related]
13. APOBEC3-mediated restriction of RNA virus replication.
Milewska A; Kindler E; Vkovski P; Zeglen S; Ochman M; Thiel V; Rajfur Z; Pyrc K
Sci Rep; 2018 Apr; 8(1):5960. PubMed ID: 29654310
[TBL] [Abstract][Full Text] [Related]
14. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of APOBEC3 activity: From anti-viral agents to anti-cancer opportunities.
Green AM; Weitzman MD
DNA Repair (Amst); 2019 Nov; 83():102700. PubMed ID: 31563041
[TBL] [Abstract][Full Text] [Related]
16. [Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis].
Shilova ON; Tsyba DL; Shilov ES
Mol Biol (Mosk); 2022; 56(1):55-68. PubMed ID: 35082258
[TBL] [Abstract][Full Text] [Related]
17. APOBECs orchestrate genomic and epigenomic editing across health and disease.
Cervantes-Gracia K; Gramalla-Schmitz A; Weischedel J; Chahwan R
Trends Genet; 2021 Nov; 37(11):1028-1043. PubMed ID: 34353635
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the Complicated Scenario of Primate APOBEC3 Gene Evolution.
Uriu K; Kosugi Y; Suzuki N; Ito J; Sato K
J Virol; 2021 May; 95(12):. PubMed ID: 33789992
[TBL] [Abstract][Full Text] [Related]
19. The role of cytidine deaminases on innate immune responses against human viral infections.
Vieira VC; Soares MA
Biomed Res Int; 2013; 2013():683095. PubMed ID: 23865062
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer transcriptomic analysis dissects immune and proliferative functions of APOBEC3 cytidine deaminases.
Ng JCF; Quist J; Grigoriadis A; Malim MH; Fraternali F
Nucleic Acids Res; 2019 Feb; 47(3):1178-1194. PubMed ID: 30624727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
